DUVEPRA owner Contact Information online
from Merck Sharp & Dohme Corp.
DUVEPRA
US serial number:85018381
Application filling date:Apr. 20, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Apr. 23, 2012
Publication date:Jul. 27, 2010
Abandoned date:Apr. 23, 2012
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment of diabetes, cardiovascular diseases and disorders, diseases and disorders of the central nervous system, cancer, osteoporosis, anti-infective preparations, immunological preparations
International Class(
Services:Pharmaceutical preparations for the treatment of diabetes
cardiovascular diseases and disorders
diseases and disorders of the central nervous system
cancer
osteoporosis
anti-infective preparations
immunological preparations
Current owner owner name:Merck Sharp & Dohme Corp.
Current owner owner address:One Merck Drive
Whitehouse Station,
NEW JERSEY
UNITED STATES
088890100
Current owner legal entity type:CORPORATION
Current owner state or country:NEW JERSEY
Attorney name:Debra A. Shelinsky Greene
Attorney email:TrademarkUS1@merck.com
Attorney email authorized:Yes
Correspondent name address:DEBRA A. SHELINSKY GREENE
MERCK SHARP & DOHME CORP.
1 MERCK DR
WHITEHOUSE STATION,
NEW JERSEY
UNITED STATES
08889-3497
Correspondent phone:908-423-5250
Correspondent email:TrademarkUS1@merck.com
Correspondent fax:908-423-1372
Correspondent email authorized:Yes
Trademark staff tm attorney:RIRIE, VERNA BETH
Trademark staff law office assigned DUVEPRA:LAW OFFICE 104
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) MERCK SHARP & DOHME CORP. (28) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Jul. 27, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
